Janus Henderson Group’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-24,666
| Closed | -$232K | – | 2544 |
|
|
2024
Q4 | $232K | Hold |
24,666
| – | – | ﹤0.01% | 2364 |
|
|
2024
Q3 | $199K | Hold |
24,666
| – | – | ﹤0.01% | 2432 |
|
|
2024
Q2 | $209K | Sell |
24,666
-237
| -1% | -$2.01K | ﹤0.01% | 2375 |
|
|
2024
Q1 | $223K | Buy |
24,903
+6
| +0% | +$54 | ﹤0.01% | 2373 |
|
|
2023
Q4 | $280K | Sell |
24,897
-40
| -0.2% | -$450 | ﹤0.01% | 2265 |
|
|
2023
Q3 | $215K | Sell |
24,937
-51
| -0.2% | -$440 | ﹤0.01% | 2345 |
|
|
2023
Q2 | $259K | Sell |
24,988
-55
| -0.2% | -$569 | ﹤0.01% | 2333 |
|
|
2023
Q1 | $272K | Buy |
25,043
+14,055
| +128% | +$152K | ﹤0.01% | 2328 |
|
|
2022
Q4 | $123K | Sell |
10,988
-10,990
| -50% | -$123K | ﹤0.01% | 2297 |
|
|
2022
Q3 | $224K | Buy |
21,978
+10,904
| +98% | +$111K | ﹤0.01% | 2355 |
|
|
2022
Q2 | $100K | Buy |
11,074
+78
| +0.7% | +$704 | ﹤0.01% | 2472 |
|
|
2022
Q1 | $105K | Sell |
10,996
-3
| -0% | -$29 | ﹤0.01% | 2553 |
|
|
2021
Q4 | $122K | Buy |
+10,999
| New | +$122K | ﹤0.01% | 2485 |
|